✦ LIBER ✦

Combination chemo-immunotherapy with adriamycin in experimental tumor systems

✍ Scribed by A. Tagliabue; N. Polentarutti; A. Vecchi; A. Mantovani; F. Spreafico

Book ID: 113145851
Publisher: Elsevier Science
Year: 1977
Weight: 714 KB
Volume: 13
Category: Article
ISSN: 0014-2964
DOI: 10.1016/0014-2964(77)90051-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of solid tumors with combined

Treatment of solid tumors with combined Chemo-immunotherapy

✍ Rasi, G.; Favalli, C.; Terzoli, E.; Izzo, F.; Sinibaldi-Vallebona, P.; Pierimarc 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Experiences with lymphocyte immunotherap

Experiences with lymphocyte immunotherapy in experimental tumor systems

✍ Bernard Fisher; Elizabeth A. Saffer; Edwin R. Fisher 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Combination chemo-immunotherapy of murin

Combination chemo-immunotherapy of murine solid tumor with OK-432, G-CSF, IL-2, and chemotherapeutics

✍ Shinichiro Iida; Setsu Matsuoka; Chie Kudo; Yoichiro Moriya; Takeshi Yoshida; Mo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 792 KB

Comparison of adriamycin with DNA-adriam

Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumors and metastases

✍ G. Atassi; M. Duarte-Karim; H.J. Tagnon 📂 Article 📅 1975 🏛 Elsevier Science ⚖ 658 KB

Immunotherapy Combined with Chemotherapy

Immunotherapy Combined with Chemotherapy in the Treatment of Tumors

✍ Frazier, James L.; Han, James E.; Lim, Michael; Olivi, Alessandro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Therapeutic effects of liposomal adriamy

Therapeutic effects of liposomal adriamycin in combination with tumor necrosis factor-α

✍ Yuji Maruo; Hiroyuki Konno; Shozo Baba 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Liposomes as drug carriers in cancer chemotherapy have attracted considerable interest. To enhance the therapeutic effect of Adriamycin entrapped in liposomes (Lip-ADM) on human solid tumors, we investigated the therapeutic effects of Lip-ADM in combination with recombinant human tumor necrosis fact